HDAC9 and melanoma: A high throughput screening of a 10,560 compound library subset from the Walter and Eliza Hall Institute, for enhancers of the HDAC inhibitor, SAHA, identified three candidate compounds that had single agent activity towards a panel of melanoma cell lines.